The challenges in establishing a regulatory pathway for biogenerics were discussed at a recent FTC roundtable, with a FDA official saying in most cases it will be “impossible” to establish that the APIs are identical.
The possible sell-off of Enzon Pharmaceuticals’ biotechnology drugs business has come under fire by one of the firm’s shareholders, DellaCamera Capital Management, which says it is opposed to the move.
The International Society for Pharmaceutical Engineering (ISPE) is
offering a "unique training experience" for pharmaceutical
professionals through a partnership with North Carolina State
University in the US.
There have been a few changes in the top ten employers according to
leading journal Science's annual survey of the best
companies to work for in the biotech, biopharma, pharmaceutical and